Evidence map›Paper›PMID 39020019›Full record

ArticleBone marrow transplantation2024

Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project.

Lars Klingen Gjærde, Oscar Brück, Nico Gagelmann, Eleni Gavriilaki, Marit Inngjerdingen, Mikko Keranen, Annika Kisch, Anders Eivind Myhre, Attilio Olivieri, Jose Antonio Perez-Simon and 14 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Lars Klingen GjærdeDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark. lars.klingen.gjaerde@regionh.dk.ORCID http://orcid.org/0000-0002-5496-9955
Oscar BrückHematoscope Lab, Comprehensive Cancer Center & Center of Diagnostics, Helsinki University Hospital, Helsinki, Finland.
Nico GagelmannDepartment of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-0891-1744
Eleni Gavriilaki2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID http://orcid.org/0000-0002-8883-8208
Marit InngjerdingenDepartment of Pharmacology, Oslo University Hospital, Oslo, Norway.
Mikko KeranenDepartment of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Annika KischDepartment of Hematology, Oncology and Radiation Physics, Skane University Hospital, Lund, Sweden.ORCID http://orcid.org/0000-0002-1536-3926
Anders Eivind MyhreDepartment of Hematology, Oslo University Hospital, Oslo, Norway.
Attilio OlivieriDepartment of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, Ancona, Italy.ORCID http://orcid.org/0000-0001-9089-9328
Jose Antonio Perez-SimonDepartment of Hematology, University Hospital Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBIS), CSIC, Universidad de Sevilla, Sevilla, Spain.ORCID http://orcid.org/0000-0003-3616-6101
Dijana PerovicInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Vladimir PerovicInstitute for Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.ORCID http://orcid.org/0000-0002-1994-1738
Agnieszka PiekarskaDepartment of Hematology and Transplantology, University Clinical Center, Medical University of Gdańsk, Gdańsk, Poland.
Drazen PulanicDivision of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Kristin RathjeDepartment of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sebastian Van VeenDepartment of Hematology, Oncology and Radiation Physics, Skane University Hospital, Lund, Sweden.
Guillaume DachyService d'Hématologie, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Ivan MoiseevRM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation.ORCID http://orcid.org/0000-0002-4332-0114
Olaf PenackDepartment for Haematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-4876-802X
Zinaida PericDepartment of Hematology, University Hospital Centre Rijeka, Rijeka, Croatia.
Hildegard GreinixDivision of Hematology, Medical University Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-2780-3300
Stephanie J LeeFred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-2600-6390
Daniel WolffDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Hélène SchoemansDepartment of Hematology, University Hospitals Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-7568-8239

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseAdultChronic DiseaseEuropeFemaleHumansLanguageMaleTranslations

Identifiers

PMID39020019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.